Prevalence of hypermutator isolates of Achromobacter spp. from cystic fibrosis patients

被引:9
|
作者
Ridderberg, Winnie [1 ]
Handberg, Kurt Jensen [1 ]
Norskov-Lauritsen, Niels [1 ]
机构
[1] Aarhus Univ Hosp, Dept Clin Microbiol, Palle Juul Jensens Blvd 99, DK-8200 Aarhus N, Denmark
关键词
Hypermutation; Cystic fibrosis; Achromobacterspp; Chronic infection; PSEUDOMONAS-AERUGINOSA; MISMATCH REPAIR; STENOTROPHOMONAS-MALTOPHILIA; MOLECULAR CHARACTERIZATION; GENETIC ADAPTATION; HIGH-FREQUENCY; XYLOSOXIDANS; INFECTIONS; STRAINS; RESISTANCE;
D O I
10.1016/j.ijmm.2020.151393
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Bacteria colonising the lungs of cystic fibrosis (CF) patients encounter high selective pressures. Hypermutation facilitates adaptation to fluctuating environments, and hypermutator strains are frequently isolated from CF patients. We investigated the prevalence of hypermutator isolates of Achromobacter spp. among patients affiliated with the CF Centre in Aarhus, Denmark. By exposure to rifampicin, the mutation frequency was determined for 90 isolates of Achromobacter spp. cultured from 42 CF patients; 20 infections were categorised as chronic, 22 as intermittent. The genetic mechanisms of hypermutation were examined by comparing DNA repair gene sequences from hypermutator and normomutator isolates. Achromobacter spp. cultured from 11 patients were categorised as hypermutators, and this phenotype was exclusively associated with chronic infections. Isolates of the Danish epidemic strain (DES) of Achromobacter ruhlandii cultured from patients from both Danish CF centres showed elevated mutation frequencies. The hypermutator state of Achromobacter spp. was most commonly associated with nonsynonymous mutations in the DNA mismatch repair gene mutS; a single clone had developed a substitution in the S-adenosyl-L-methionine-dependent methyltransferase putatively involved in DNA repair mechanisms, but not previously linked to the hypermutator phenotype. Hypermutation is prevalent among clinical isolates of Achromobacter spp. and could be a key determinant for the extraordinary adaptation and persistence of DES.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Achromobacter spp. prevalence and adaptation in cystic fibrosis lung infection
    Veschetti, Laura
    Boaretti, Marzia
    Saitta, Giulia Maria
    Mantovani, Rebeca Passarelli
    Lleo, Maria M.
    Sandri, Angela
    Malerba, Giovanni
    MICROBIOLOGICAL RESEARCH, 2022, 263
  • [2] Mobilome Analysis of Achromobacter spp. Isolates from Chronic and Occasional Lung Infection in Cystic Fibrosis Patients
    Veschetti, Laura
    Sandri, Angela
    Patuzzo, Cristina
    Melotti, Paola
    Malerba, Giovanni
    Lleo, Maria M.
    MICROORGANISMS, 2021, 9 (01) : 1 - 10
  • [3] Achromobacter spp. genetic adaptation in cystic fibrosis
    Gabrielaite, Migle
    Nielsen, Finn C.
    Johansen, Helle K.
    Marvig, Rasmus L.
    MICROBIAL GENOMICS, 2021, 7 (07):
  • [4] Prevalence and molecular characterization of azole resistance in Aspergillus spp. isolates from German cystic fibrosis patients
    Fischer, J.
    van Koningsbruggen-Rietschel, S.
    Rietschel, E.
    Vehreschild, M. J. G. T.
    Wisplinghoff, H.
    Kroenke, M.
    Hamprecht, A.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2014, 69 (06) : 1533 - 1536
  • [5] Characterization of Hypermutator Pseudomonas aeruginosa Isolates from Patients with Cystic Fibrosis in Australia
    Rees, Vanessa E.
    Lucas, Deanna S. Deveson
    Lopez-Causape, Carla
    Huang, Yuling
    Kotsimbos, Tom
    Bulitta, Jurgen B.
    Rees, Murray C.
    Barugahare, Adele
    Peleg, Anton Y.
    Nation, Roger L.
    Oliver, Antonio
    Boyce, John D.
    Landersdorfer, Cornelia B.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (04)
  • [6] Effect of respiratory Achromobacter spp. infection on pulmonary function in patients with cystic fibrosis
    Recio, R.
    Branas, P.
    Martinez, M. T.
    Chaves, F.
    Orellana, M. A.
    JOURNAL OF MEDICAL MICROBIOLOGY, 2018, 67 (07) : 952 - 956
  • [7] In Vivo Inflammation Caused by Achromobacter spp. Cystic Fibrosis Clinical Isolates Exhibiting Different Pathogenic Characteristics
    Sandri, Angela
    Saitta, Giulia Maria
    Veschetti, Laura
    Boschi, Federico
    Mantovani, Rebeca Passarelli
    Carelli, Maria
    Melotti, Paola
    Signoretto, Caterina
    Boaretti, Marzia
    Malerba, Giovanni
    Lleo, Maria M.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (08)
  • [8] Impact of Achromobacter spp. isolation on clinical outcomes in children with cystic fibrosis
    Sunman, Birce
    Emiralioglu, Nagehan
    Hazirolan, Gulsen
    Tural, Dilber Ademhan
    Ozsezen, Beste
    Buyuksahin, Halime Nayir
    Guzelkas, Ismail
    Yalcin, Ebru
    Dogru, Deniz
    Ozcelik, Ugur
    Kiper, Nural
    PEDIATRIC PULMONOLOGY, 2022, 57 (03) : 658 - 666
  • [9] Role of Efflux in Antibiotic Resistance of Achromobacter xylosoxidans and Achromobacter insuavis Isolates From Patients With Cystic Fibrosis
    Chalhoub, Hussein
    Kampmeier, Stefanie
    Kahl, Barbara C.
    Van Bambeke, Francoise
    FRONTIERS IN MICROBIOLOGY, 2022, 13
  • [10] Molecular Characterization of Achromobacter Isolates from Cystic Fibrosis and Non-Cystic Fibrosis Patients in Madrid, Spain
    Barrado, Laura
    Branas, Patricia
    Angeles Orellana, M.
    Teresa Martinez, M.
    Garica, Gloria
    Otero, Joaquin R.
    Chaves, Fernando
    JOURNAL OF CLINICAL MICROBIOLOGY, 2013, 51 (06) : 1927 - 1930